Burkholderia pseudomallei (Melioidosis)
LEVELS: Likely to occur: Effective control measures not fully understood; Occupational exposure risk: Non-foodborne transmission pathway(s) that are strongly associated with occupational exposure and can lead to human infection; Unlikely to be effective: One or more pathways of farm-to-farm transmission exist that cannot be controlled by on-farm biosecurity; Moderate: Clinical signs not unique but existing tests available at local/regional laboratory(s); Minor: Low prevalence, typically non-lethal infection with recovery very likely; Significant disruption: Measureable negative effect on demand for 1 to 6 months when disease occurs on one or more farms; Minimal risk: Agent inherently unlikely to develop clinically important resistance to antibacterial or antiviral treatments; Minimal risk: Antibacterial or antiviral treatments rarely occur, or are typically limited to short-course individual animal therapy; Available but with uncertain efficacy: Limited treatments available in US or are only effective in some situations; No availability: Effective vaccines not currently available in the US (or have not been developed); Not feasible: Eradication extremely unlikely
Criteria Levels
- Foodborne Zoonotic Transmission: Documented foodborne transmission
- Non-Foodborne Zoonotic Transmission: Documented non-foodborne zoonotic transmission
- Beyond-Farm Spread Potential: Spreads despite standard measures
- Detection Difficulty: Moderate detection requiring specialized testing
- Financial Impact - Mortality and Morbidity Costs: Sporadic losses with occasional significant impacts
- Financial Impact - Prevention and Control Costs: Significant disruption requiring enhanced measures
- Antimicrobial Resistance - Pathogen Risk: No AMR concern
- Antimicrobial Resistance - Treatment Impact: Minimal AMR concern from disease management
- Treatment Availability: Limited treatment options
- Vaccine Availability: No effective vaccine
- Eradication Feasibility: Not feasible to eradicate
Detailed Justification
1. Foodborne Zoonotic Transmission
Level: Documented foodborne transmission
The chapter explicitly confirms foodborne risk: - "Both pigs and people may contract the infection from animals by consumption of contaminated meat" - "Ingestion of improperly cooked meat from infected animals may also result in human infection"
Foodborne transmission from undercooked pork is a documented route for human melioidosis.
2. Non-Foodborne Zoonotic Transmission
Level: Documented non-foodborne zoonotic transmission
Multiple non-foodborne transmission routes exist: - Water contaminated by animal or human feces - Environmental sources (soil, water in endemic areas) - "Recent outbreaks in the United States from imported aromatherapy sprays highlight the risk from inhalation and potential risks from some imported products"
The organism is present in environmental reservoirs, and transmission can occur through contact with contaminated water/soil or inhalation of aerosolized material.
3. Beyond-Farm Spread Potential
Level: Spreads despite standard measures
B. pseudomallei is an environmental saprophyte that defies standard biosecurity: - "Burkholderia pseudomallei is present in water and soil in tropical and subtropical areas and may infect pigs when water supplies are contaminated" - "A recent outbreak in Thailand identified contaminated water as a source" - The organism persists in environmental reservoirs independent of animal hosts
Standard biosecurity measures focused on animal-to-animal transmission cannot prevent environmental exposure in endemic regions. The pathogen's saprophytic nature means it can spread to farms through contaminated water or soil without any animal movement.
4. Detection Difficulty
Level: Moderate detection requiring specialized testing
Clinical presentation is often subclinical or nonspecific: - "Infection is often clinically inapparent" - When clinical signs occur, they are nonspecific: "raised rectal temperature... may develop for up to 4 days. Unsteady gait, lameness or weakness, slight nasal discharge, and subcutaneous swellings of the limbs may be seen"
The chapter notes diagnostic limitations: - "Precaution should be used to ensure the organism is included in the instrument database" for MALDI-TOF identification - "More frequently, presumptive diagnosis is based on the presence of creamy abscesses found at slaughter"
Laboratory confirmation requires culture on selective media or specialized identification methods. The organism's select agent status (Tier 1) also restricts routine testing capabilities.
5. Financial Impact - Mortality and Morbidity Costs
Level: Sporadic losses with occasional significant impacts
Disease characteristics suggest sporadic occurrence with occasional significant losses: - "Deaths may occur but are rare in adults" - "Abortions and uterine discharges have been recorded" - Lesions primarily discovered at slaughter as "large abscesses filled with creamy or caseous yellow–green pus in the lungs, liver, spleen, kidney, and mesenteric and subcutaneous lymph nodes"
The disease is regional (tropical/subtropical) and sporadic rather than endemic in commercial operations. Production losses occur when water sources are contaminated but are not sustained.
6. Financial Impact - Prevention and Control Costs
Level: Significant disruption requiring enhanced measures
B. pseudomallei's classification creates significant regulatory implications: - "B. pseudomallei is listed as a tier 1 select agent under the US Federal Select Agent Program" - "As the disease is of public health importance, infected carcasses should be disposed of safely" - "Rigorous criteria for meat inspection of slaughter pigs will help to safeguard public health"
The select agent designation, zoonotic risk, and need for enhanced meat inspection create regulatory and operational burdens beyond routine disease management.
7. Antimicrobial Resistance - Pathogen Risk
Level: No AMR concern
The organism has intrinsic resistance to some antibiotics but not acquired resistance of broader concern: - "Burkholderia pseudomallei is resistant in vitro to aminoglycosides" - "Susceptible to some cephalosporins and to amoxicillin with clavulanic acid"
This represents inherent species characteristics rather than acquired resistance that could spread to other pathogens. B. pseudomallei is not identified as a reservoir for transferable resistance genes.
8. Antimicrobial Resistance - Treatment Impact
Level: Minimal AMR concern from disease management
The rarity of clinical disease in swine means treatment is infrequent: - Most infections are subclinical - Disease is regionally limited - Treatment of individual animals would be rare
No population-level antimicrobial programs exist for this sporadic environmental pathogen.
9. Treatment Availability
Level: Limited treatment options
Treatment is complicated by intrinsic resistance: - "Resistant in vitro to aminoglycosides" - eliminating a major class of antibiotics - "Susceptible to some cephalosporins and to amoxicillin with clavulanic acid"
The limited range of effective antibiotics, combined with the often-subclinical nature of infection (lesions discovered at slaughter), means treatment opportunities are restricted. In humans, melioidosis requires prolonged treatment with specific antibiotics - similar challenges would apply in swine.
10. Vaccine Availability
Level: No effective vaccine
No vaccine is mentioned for either swine or humans. Prevention relies on avoiding environmental exposure: - "The disease can be prevented by the use of clean or chlorinated water supplies and by preventing access to contaminated soil"
11. Eradication Feasibility
Level: Not feasible to eradicate
The organism is a saprophyte that persists indefinitely in environmental reservoirs: - "Present in water and soil in tropical and subtropical areas" - The disease "is likely severely underreported" suggesting widespread environmental contamination - Serological surveys show 6.3% positivity in Vietnamese pigs
Eradication is impossible because the organism lives in the environment independent of animal hosts. Even if all infected animals were removed, reinfection would occur from contaminated water and soil in endemic areas.
Summary
Burkholderia pseudomallei causes melioidosis, a chronic bacterial infection seen in tropical and subtropical regions. While uncommon in commercial swine, it represents a significant One Health concern due to its environmental persistence, multiple zoonotic transmission routes (foodborne, waterborne, inhalation), and Tier 1 select agent classification. The organism defies standard biosecurity by persisting in soil and water. Clinical disease is often inapparent, with lesions discovered at slaughter. Treatment options are limited by intrinsic aminoglycoside resistance. No vaccine exists, and eradication is impossible given the saprophytic nature of the pathogen. The primary concerns are public health risk and regulatory implications of the select agent designation.